All Categories
GEFCY-250
It is a drug used for certain breast, lung and other cancers. Gefitinib is the first selective inhibitor of epidermal growth factor receptor’s (EGFR) tyrosine kinase domain. Thus Gefitinib is an EGFR inhibitor. The target protein (EGFR) is a family of receptors which includes Her 1(erb-B1), Her 2(erb-B2), and Her 3(erb-B3). EGFR is over expressed in the...
IMACY-100
IMACY-100mgTyrosine kinase inhibitors (TKIs) have been approved for cancer treatment and numerous are under investigation. These drugs are rationally designed to target specific tyrosine kinases that are mutated and/or over-expressed in cancer tissues. Ninety-five percent of all chronic myelogenous leukemia (CML) was suggested to be the result of the...
IMACY-400
IMACY-400mg n Tyrosine kinase inhibitors (TKIs) have been approved for cancer treatment and numerous are under investigation. These drugs are rationally designed to target specific tyrosine kinases that are mutated and/or over-expressed in cancer tissues.Ninety-five percent of all chronic myelogenous leukemia (CML) was suggested to be the result of the...
Dasatinib-20
DASATINIB-20mgDasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL).Kinase inhibitors prevent the growth of tumours by reducing the action of proteins that control cell...
Dasatinib-50
DASATINIB-50mgDasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL).Kinase inhibitors prevent the growth of tumours by reducing the action of proteins that control cell...
- 1
- 2